|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
73,340,000 |
Market
Cap: |
N/A |
Last
Volume: |
924,021 |
Avg
Vol: |
428,643 |
52
Week Range: |
$124.7 - $124.7 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Lundberg Magnus |
Director |
|
2013-03-11 |
4 |
OE |
$38.85 |
$194,250 |
D/D |
5,000 |
17,116 |
|
- |
|
Wiggans Thomas G |
Director |
|
2013-03-08 |
4 |
AS |
$85.00 |
$170,000 |
D/D |
(2,000) |
8,065 |
|
- |
|
Wiggans Thomas G |
Director |
|
2013-03-08 |
4 |
OE |
$27.63 |
$55,260 |
D/D |
2,000 |
10,065 |
|
- |
|
Goddard Paul |
Director |
|
2013-03-08 |
4 |
AS |
$85.00 |
$85,000 |
D/D |
(1,000) |
12,790 |
|
- |
|
Goddard Paul |
Director |
|
2013-03-08 |
4 |
OE |
$28.41 |
$28,410 |
D/D |
1,000 |
13,790 |
|
- |
|
Shema Suzanne M |
EVP, GC and Corp. Secretary |
|
2013-03-07 |
4 |
AS |
$79.72 |
$323,185 |
D/D |
(4,054) |
33,833 |
|
- |
|
Shema Suzanne M |
EVP, GC and Corp. Secretary |
|
2013-03-07 |
4 |
OE |
$30.28 |
$139,072 |
D/D |
4,054 |
37,887 |
|
- |
|
Fust Matthew K |
EVP & Chief Financial Officer |
|
2013-03-05 |
4 |
OE |
$34.48 |
$76,235 |
D/D |
2,211 |
47,412 |
|
- |
|
Wiggans Thomas G |
Director |
|
2013-03-05 |
4 |
AS |
$77.20 |
$193,000 |
D/D |
(2,500) |
8,065 |
|
- |
|
Wiggans Thomas G |
Director |
|
2013-03-05 |
4 |
OE |
$25.30 |
$63,250 |
D/D |
2,500 |
10,565 |
|
- |
|
Goddard Paul |
Director |
|
2013-03-01 |
4 |
AS |
$74.35 |
$297,400 |
D/D |
(4,000) |
12,790 |
|
- |
|
Goddard Paul |
Director |
|
2013-03-01 |
4 |
OE |
$12.50 |
$50,000 |
D/D |
4,000 |
16,790 |
|
- |
|
Fust Matthew K |
EVP & Chief Financial Officer |
|
2013-02-28 |
4 |
AS |
$77.12 |
$1,156,800 |
D/D |
(15,000) |
45,201 |
|
- |
|
Fust Matthew K |
EVP & Chief Financial Officer |
|
2013-02-28 |
4 |
OE |
$34.48 |
$344,800 |
D/D |
10,000 |
60,201 |
|
- |
|
Foster-Cheek Kaye I |
SVP, Global Human Resources |
|
2013-02-15 |
4 |
AS |
$74.96 |
$1,211,653 |
D/D |
(16,164) |
25,499 |
|
- |
|
Foster-Cheek Kaye I |
SVP, Global Human Resources |
|
2013-02-15 |
4 |
OE |
$26.38 |
$493,186 |
D/D |
16,164 |
41,663 |
|
- |
|
Shema Suzanne M |
EVP, GC and Corp. Secretary |
|
2013-02-07 |
4 |
AS |
$77.52 |
$314,034 |
D/D |
(4,051) |
33,833 |
|
- |
|
Shema Suzanne M |
EVP, GC and Corp. Secretary |
|
2013-02-07 |
4 |
OE |
$30.28 |
$138,972 |
D/D |
4,051 |
37,884 |
|
- |
|
Wiggans Thomas G |
Director |
|
2013-02-05 |
4 |
AS |
$77.29 |
$193,225 |
D/D |
(2,500) |
8,065 |
|
- |
|
Wiggans Thomas G |
Director |
|
2013-02-05 |
4 |
OE |
$25.30 |
$63,250 |
D/D |
2,500 |
10,565 |
|
- |
|
Torley Helen |
EVP, Chief Commercial Officer |
|
2013-02-04 |
4 |
AS |
$78.61 |
$648,533 |
D/D |
(8,250) |
39,512 |
|
- |
|
Torley Helen |
EVP, Chief Commercial Officer |
|
2013-02-04 |
4 |
OE |
$33.70 |
$283,000 |
D/D |
8,250 |
47,762 |
|
- |
|
Wierenga Wendall D |
Director |
|
2013-02-01 |
4 |
AS |
$77.71 |
$19,428 |
D/D |
(250) |
9,080 |
|
- |
|
Fust Matthew K |
EVP & Chief Financial Officer |
|
2013-01-10 |
4 |
AS |
$84.41 |
$865,582 |
D/D |
(10,199) |
50,201 |
|
- |
|
Fust Matthew K |
EVP & Chief Financial Officer |
|
2013-01-10 |
4 |
OE |
$34.48 |
$245,222 |
D/D |
7,112 |
60,400 |
|
- |
|
688 Records found
|
|
Page 6 of 28 |
|
|